Start up companies and biotech engineering is making a big calling as nobody wants or likes the formulas that crippled Wall Street any longer. There’s a lot of work in R and D though where formulas and scientific study are needed to cure diseases, that is for sure. Hopefully all our well educated...
Posted to
The Medical Quack .... by Barbara Duck
on 11-14-2008
Filed under: Medically Related, Technology, Other Items of Interest, Genomics, healthcare, Biotech, Start Ups, Wall Street, Algorithms, Engineers
This is a real interesting merger with a biotech company patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system merging with a company that provides personal health records, both companies from California. Favrille is involved in clinical trials...
Posted to
The Medical Quack .... by Barbara Duck
on 11-10-2008
Filed under: Medically Related, Technology, healthcare, Biotech, PHR, Google Health, Cancer, clinical trials, Personal Health Records, R and D
This interview from Charlie Roses touches on many items and Nobel Prize Winner Muhammad Yunus adds what he has been able to accomplish in his part of the world in Bangladesh and how some of those principles can be applied here, coming together of both sides, different minds, different ideas that can...
Posted to
The Medical Quack .... by Barbara Duck
on 10-28-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, healthcare, Biotech, Cancer, Pharmaceuticals, R and D, Economy, Banking, Milken Institute, Mahammed Yunus, Milken, Charlie Rose
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 10-26-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
The group has grown in 7 years from five people focused on healthcare worldwide at Microsoft; now there are more than 700. This group is for responsible primarily for the enterprise space (in biopharma and medical devices), so these are the largest customers in the U.S. I have provided a...
Posted to
The Medical Quack .... by Barbara Duck
on 10-09-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Microsoft/Windows News, personalized medicine, Genomics, healthcare, microsoft, Medical Records, Biotech, R and D, Server 2008, Life Sciences, SharePoint, Windows Presentation Foundation, HPC Server 2008
It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
Previously he has donated $20 million to Stanford for the Lorry I. Lokey Laboratory Building, which houses research labs for the departments of Chemistry and Biological Sciences. He founded Business Wire, the international public relations wire service, in 1961. This furthers his commitment...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, healthcare, Biotech, R and D, Stem Cells, Stanford University, Donation, Philanthropy